Advanced Staining Solution to Accelerate Diagnostic Productivity for Mid-Sized and Large Labs

A more advanced and faster staining solution enables single or STAT slides to be processed in just one hour, allowing pathologists to quickly provide diagnoses, which is crucial for patients requiring urgent diagnostic decisions. This solution reduces the average turnaround time (TAT) for immunohistochemistry (IHC) slides to approximately 90 minutes and ensures 100% instrument utilization without constant supervision.

Leica Biosystems (Nussloch, Germany) has announced the European launch of the BOND-PRIME advanced staining solution, which seamlessly adapts and optimizes workflow to stain slides as required, without leaving any slide staining position unused. It features 70 open-access reagent positions and a total on-board capacity of 72 slides. Besides its adaptability and speed, the platform incorporates innovative technology to further improve the staining quality available to laboratories. This results in consistently sharp, clean stains that are gentle on sample tissue and exhibit minimal carry-over. Leica has introduced Active Reagent Control (ARC) to enable highly controlled reagent application and incubation. BOND-PRIME is now accessible for in vitro diagnostic use in specific countries within the EMEA regions, as well as the United States, Canada, Australia, and New Zealand.

“In today’s fast-paced healthcare environment, adaptability is essential to ensure that slides are processed in a timely manner, without compromising on quality,” explained Colin White, Senior Vice President of Advanced Staining, and Imaging. “BOND-PRIME is a generation ahead. It enables labs to achieve a high-speed, continuous workflow, an average single slide TAT of 90 minutes, no downtime and minimal need for manual intervention. The impact on quality and productivity is truly impressive.”

“We have a history of innovation that addresses specific customer needs,” said Gustavo Perez-Fernandez, President at Leica Biosystems. “The BOND-PRIME staining solution presents a quantifiable benefit to mid-sized and large laboratories in terms of both quality and greater efficiency. STAT cases can be processed quickly and efficiently, without holding back the validation of more routine cases. By streamlining workflow, the use of BOND-PRIME ensures that fewer cases overall are left pending.”

Related Links:
Leica Biosystems